Find trials
Search tips

Impact of Three vs Seven Day Stent Placement on Symptoms

Overview

About this study

The purpose of this study is to determine whether patients would have improved symptoms with a shorter duration of stent placement without negative impact.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Individuals ≥ 18 years of age.
  • Uncomplicated Ureteroscopy. 
  • Stones < 2 cm.
  • Unilateral Stone Treatment.

Exclusion Criteria:

  • Age < 18.
  • Pregnant.
  • Pre-stent placement or nephrostomy tube/infected stone.
  • Ureteral stricture/complex ureteroscopy.
  • Transplant kidney.
  • Variant anatomy (horseshoe, pelvic kidney).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 1/24/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kevin Wymer, M.D.

Open for enrollment

Contact information:

Kevin Wymer M.D.

(507) 284-2511

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Karen Stern, M.D.

Open for enrollment

Contact information:

Debra Ryan CCRP

(480) 342-1208

Ryan.Debra29@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20557552

Mayo Clinic Footer